Efficacy and safety of immune checkpoint inhibitor nivolumab and radiotherapy combination in advanced NSCLC

Authors :: F. Lancia
F. Daniel
L.R. Martella
Antonio Frassoldati
Benedetta Urbini
A. Santini
Lorenzo Belluomini
Stefanelli A
I. Toma
Carlo Alberto Giorgi
E. Bannò
A. Moretti
Fiorica F
Source :: Annals of Oncology. 28:vi64
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
Radiation therapy
medicine.medical_specialty
business.industry
Immune checkpoint inhibitors
medicine.medical_treatment
Internal medicine
medicine
Hematology
Nivolumab
business

Tools